SAN DIEGO, May 1, 2020 /PRNewswire/ -- Evofem Biosciences,
Inc. (NASDAQ: EVFM), a clinical-stage biopharmaceutical company,
today announced that the location of its annual general meeting
scheduled for May 12, 2020 at
8:00 am PDT has been moved to the
6th floor boardroom at 12400 High Bluff Dr.,
San Diego, CA 92130.
In light of the COVID-19 pandemic, attendees will be required to
wear a self-provided mask or cloth face covering while on the
premises, and required to practice social distancing. Any person in
attendance who exhibits cold, fever or flu-like symptoms or who has
been exposed to COVID-19 may be asked to leave the premises for the
protection of the other attendees. Evofem reserves the right to
take any additional precautionary measures it deems appropriate in
relation to the physical meeting and access to its
premises.
In lieu of in-person attendance, shareholders are encouraged to
vote in accordance with the instructions set forth in the proxy
statement and submit proxies in advance of the Annual Meeting.
About Evofem Biosciences, Inc.
Evofem Biosciences,
Inc., (NASDAQ: EVFM) is a clinical-stage biopharmaceutical company
committed to developing and commercializing innovative products to
address unmet needs in women's sexual and reproductive health.
Evofem Biosciences aims to advance the lives of women by developing
innovative solutions, such as woman-controlled contraception and
potential protection from certain sexually transmitted infections
(STIs). The Company's lead product candidate, Phexxi™, is currently
being reviewed by the U.S. Food and Drug Administration for
prevention of pregnancy. The investigational candidate EVO100
is being evaluated for prevention of urogenital transmission of
both Chlamydia trachomatis infection (chlamydia)
and Neisseria gonorrhoeae infection (gonorrhea) in
women. For more information regarding Evofem, please
visit www.evofem.com.
Phexxi™ and Multipurpose Vaginal pH Regulator (MVP-R™) are
trademarks of Evofem Biosciences, Inc.
Investor Contact
Amy
Raskopf
Evofem Biosciences, Inc.
araskopf@evofem.com
M: (917) 673-5775
Media Contact
Cara
Miller
Evofem Biosciences, Inc.
cmiller@evofem.com
O: (858) 550-1900 x272
View original content to download
multimedia:http://www.prnewswire.com/news-releases/evofem-biosciences-announces-new-location-and-covid-19-preventative-measures-for-2020-annual-meeting-scheduled-for-may-12-2020-301051211.html
SOURCE Evofem Biosciences, Inc.